Kraig Labs opens R&D headquarters to media for the first time
ANN ARBOR, Mich., – May 13, 2019 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that its recombinant spider silk technology will be featured in a documentary focused on combating terrorism. The Company opened the doors of its R&D headquarters, for the first time to the media, to host a French documentary film crew and provided them with access to the process of creating its incredible spider silk technologies.
Tougher and more flexible than competing materials, spider silk offers the promise of increased protection, comfort, and mobility in protective textile applications. In addition to this documentary, the Company has been covered by numerous media outlets, including the following T.EVO, Textile Evolution, article; https://www.tevonews.com/fibres-yarns-news/2026-polartec-figureheads-discuss-kraig-labs-silkworm-solution.
“Our team is incredibly proud of the work we do here and the impact that our Company is already making in these important markets,” said COO Jon Rice. “It was a pleasure to be able to share the results of our efforts and to showcase this amazing technology along with its potential to disrupt the protective textile and related markets.”
The series is planned to air in the fall of 2019. Although the footage was shot at Kraig Labs’ R&D headquarters in Michigan, the Company continues to focus its efforts on scaling up its production operations, through its subsidiary, Prodigy Textiles Ltd., in Asia. By utilizing the existing global silk infrastructure and Kraig Labs’ engineered silkworm technology, the Company set to meet cost and volume metrics, previously thought to be impossible, in the commercialization of spider silk for these lifesaving applications in protective textiles.
To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.
The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC
(720) 288-8495